Elite Pharmaceuticals (ELTP) Asset Utilization Ratio (2009 - 2026)
Elite Pharmaceuticals' Asset Utilization Ratio was 1.02 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 5.2% from 1.08 a year earlier but up 0.5% from the prior quarter.
Elite Pharmaceuticals (ELTP) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Asset Utilization Ratio at Elite Pharmaceuticals came in at 1.27, up 35.9% from FY2025.
- Asset Utilization Ratio has now increased for three consecutive fiscal years.
- In earlier fiscal years, Asset Utilization Ratio was 0.93 in FY2025 (+2.7%), 0.91 in FY2024 (+1.2%), 0.90 in FY2023 (-14.6%) and 1.05 in FY2022 (+6.0%).
- Quarterly Asset Utilization Ratio has moved between 0.64 (fiscal Q3 2023) and 1.15 (fiscal Q3 2026) over five years.
- Compared with a year earlier, Asset Utilization Ratio was higher in six of the last eight quarters, with growth averaging 22.1%.
- The best year-over-year quarter for Asset Utilization Ratio over five years was fiscal Q3 2026 (growth of 47.0%); the worst was fiscal Q3 2023 (a decline of 30.5%).
- Per Business Quant data, ELTP's Asset Utilization Ratio in the three fiscal quarters before Q2 2027 was 1.01 (Q1 2027), 1.12 (Q4 2026) and 1.15 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,286.92 Bn | 1,260.54 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 686.05 Bn | 605.91 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 523.52 Bn | 491.53 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 361.19 Bn | 324.13 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 313.37 Bn | 286.61 Bn | - | - |
| 6 | Astrazeneca | 286.61 Bn | 260.13 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 252.56 Bn | 204.21 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 210.02 Bn | 185.12 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 164.90 Bn | 112.26 Bn | 12.56 Bn | 0.31 |
| 10 | Elite Pharmaceuticals | 395.85 Mn | 269.26 Mn | 15.99 Mn | 1.02 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.02 |
| Jun 30, 2026 | 1.01 |
| Mar 31, 2026 | 1.12 |
| Dec 31, 2025 | 1.15 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 1.02 |
| Mar 31, 2025 | 0.90 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.81 |
| Jun 30, 2024 | 0.77 |
| Mar 31, 2024 | 0.72 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.70 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.73 |
| Dec 31, 2022 | 0.64 |
| Sep 30, 2022 | 0.67 |
| Jun 30, 2022 | 0.79 |
| Mar 31, 2022 | 0.96 |
| Dec 31, 2021 | 0.93 |
Elite Pharmaceuticals Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();